Straits Times Index
3,316.56 -6.06 (-0.18%) S&P 500
5,304.72 +36.88 (+0.70%) Dow
39,069.59 +4.29 (+0.01%) Nasdaq
16,920.79 +184.79 (+1.10%) Bitcoin USD
68,690.38 -413.79 (-0.60%) CMC Crypto 200
1,489.88 +21.78 (+1.48%)
RMD Jun 2024 220.000 put
| Previous close | 7.83 |
| Open | 7.83 |
| Bid | 8.80 |
| Ask | 9.30 |
| Strike | 220.00 |
| Expiry date | 2024-06-21 |
| Day's range | 7.83 - 7.83 |
| Contract range | N/A |
| Volume | |
| Open interest | 278 |
ZacksCharles River (CRL) Banks on RMS Growth Amid Competition
Charles River's (CRL) RMS arm sees lesser impact on demand than other life science sectors despite macroeconomic challenges in China.
ZacksScoop up These 4 GARP Stocks to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. CSL, RMD, BAH and BAP are some stocks that hold promise.
GlobeNewswireDeveloped in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA)Prevalence of OSA in the United States expected to increase 26.7% in men and women aged 30 –70Real-world trends of glucagon-like peptide-1 (GLP-1) receptor agonist and PAP therapy use show patients who were adherent to their GLP-1 medication had higher levels of PAP therapy use than those
